Clinical Trial Update: Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing ascorbic acid administration for anemia in chronic hemodialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Disease
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Anemia Working Group Romania | Conditions: Anaemia Response to the Treatment, Peripheral Iron Indices | Phase 4 | Status: UNKNOWN